LRRK2 and Parkinson disease: Another study showed that patient-derived dermal fibroblasts and iPSCs harboring PD-associated mutations in LRRK2 exhibited a significant decrease in maximal reserve capacity and reduced complex I activity, a mitochondrial pathology that is reversed when inorganic nitrite is administered to activate the antioxidant Nrf2 pathway [197].